HOME >> BIOLOGY >> NEWS
Scary study: Selenium deficiency causes flu virus to mutate into more dangerous forms

(Embargoed) CHAPEL HILL -- Influenza virus that has been passed through mice deficient in the trace nutrient selenium mutates and emerges from the mice more virulent than before, a new study shows. While the research was limited to rodents, it's likely that something similar happens in humans deficient in selenium and, possibly, in other nutrients, University of North Carolina at Chapel Hill scientists say. That's because humans and mice are so similar biologically, and the mice were infected with a human influenza virus.

A report on the discovery appears in the June 8 issue of the FASEB Journal, a scientific journal published by the Federation of American Societies for Experimental Biology. Authors include Dr. Melinda A. Beck, associate professor of pediatrics and nutrition at the UNC schools of medicine and public health, and Heather K. Nelson, a doctoral student in nutrition at UNC. Dr. Orville A. Levander, a research chemist with the Agricultural Research Service's Beltsville Human Nutrition Research Center, who specializes in selenium, also contributed to the study.

In April, the scientists reported discovering that inadequate intake of selenium boosts damage caused by influenza viruses.

"We believe our latest findings are both important and potentially disturbing because they suggest nutritional deficiencies can promote epidemics in a way not appreciated before," Beck said. "Here we looked at flu virus because it hospitalizes more than 100,000 people each year in the United States alone. But what we found conceivably could be true for any RNA virus -- cold virus, AIDS virus and Ebola virus."

She and Nelson worked with colleagues at the U.S. Department of Agriculture and the Nestle Research Center in Switzerland. They fed groups of mice either selenium-deficient or normal diets. Later, they exposed both groups to a mild strain of human influenza virus known as Influenza A Bangkok. Rodents consuming too
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
7-Jun-2001


Page: 1 2 3

Related biology news :

1. Chernobyl study: Risk of thyroid cancer rises with radiation dose
2. UW study: Migrating birds offer insight into sleep
3. UF study: Barren Siberia, of all places, may be original home to animal life
4. Comprehensive study: We know little about environmental effects on kids
5. UW study: Babys face lights up emotional center of new moms brain
6. UF study: World shark attacks sink again, may signal long-term trend
7. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
8. New study: percentage of babies born with intestinal birth defect growing in U.S., N.C.
9. MIT study: Hydrogen car no environmental panacea
10. UF study: Calorie restriction reduces age-related brain cell death
11. USF study: Nicotine antagonist relieves depression in children with Tourettes

Post Your Comments:
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
(Date:5/20/2013)... ITHACA, N.Y. Little is known about the effect ... new study from Cornell University finds that increasing the ... class reduces the probability of obesity. , The study ... effect of PE on youth obesity, and is forthcoming ... An early, online version of the study can be ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
(Date:5/21/2013)... 21, 2013 As the R&D ... push within the industry to deliver better products, ... and pharma companies often means turning big ideas ... developed in collaboration with Sensidose AB and Recipharm, ... bring products to market sooner. The partnership resulted ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Bed bugs have ... to My Cleaning Products, many turn to chemical-based pesticides for ... the health and environmental risks those solutions present, the company ... Bed Bug Bully instead. , According to My Cleaning ... as they used to be. It shared that the pests ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
Cached News: